Relief from Zmp1-mediated arrest of phagosome maturation is associated with facilitated presentation and enhanced immunogenicity of mycobacterial antigens.
about
Current efforts and future prospects in the development of live mycobacteria as vaccinesMycobacterium tuberculosis EsxH inhibits ESCRT-dependent CD4+ T-cell activationBCG vaccine mediated reduction in the MHC-II expression of macrophages and dendritic cells is reversed by activation of Toll-like receptors 7 and 9.The endothelin system has a significant role in the pathogenesis and progression of Mycobacterium tuberculosis infection.Novel GMO-Based Vaccines against Tuberculosis: State of the Art and Biosafety ConsiderationsAntigen processing and remodeling of the endosomal pathway: requirements for antigen cross-presentation.A Modified Bacillus Calmette-Guérin (BCG) Vaccine with Reduced Activity of Antioxidants and Glutamine Synthetase Exhibits Enhanced Protection of Mice despite Diminished in Vivo Persistence.Differential Effects of Mycobacterium bovis BCG on Macrophages and Dendritic Cells from Murine SpleenCharacterization of a New M13 Metallopeptidase from Deep-Sea Shewanella sp. E525-6 and Mechanistic Insight into Its Catalysis.Current and novel approaches to vaccine development against tuberculosis.Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol InfectionMycobacterium tuberculosis Zinc Metalloprotease-1 Elicits Tuberculosis-Specific Humoral Immune Response Independent of Mycobacterial Load in Pulmonary and Extra-Pulmonary Tuberculosis Patients.Mycobacterium tuberculosis Zinc Metalloprotease-1 Assists Mycobacterial Dissemination in Zebrafish.Immunoevasion and immunosuppression of the macrophage by Mycobacterium tuberculosis.Murine Flt3 ligand-generated plasmacytoid and conventional dendritic cells display functional differentiation in activation, inflammation, and antigen presentation during BCG infection in vitro.TBVAC2020: Advancing Tuberculosis Vaccines from Discovery to Clinical DevelopmentMycobacterium tuberculosis Molecular Determinants of Infection, Survival Strategies, and Vulnerable Targets.Next-Generation Vaccines Based on Bacille Calmette-Guérin.Deletion of BCG Hip1 protease enhances dendritic cell and CD4 T cell responses.Molecular Mechanisms of Intrinsic Streptomycin Resistance in Mycobacterium abscessus.Rapid loss of early antigen-presenting activity of lymph node dendritic cells against Ag85A protein following Mycobacterium bovis BCG infection.
P2860
Q28087077-23C1CEFF-6F54-4D17-BAD3-D6C4E2DB348AQ33751370-F6DC3FFE-3F8A-493F-AF06-E0FBC11E813CQ33893983-49078C79-D18A-4392-8080-FE83DAFBFEA7Q34595822-83A205BB-5114-44F6-9F2F-385EC4542101Q35826779-8024E279-4C9A-4EAC-88E9-ED6DBFF8C159Q35928276-F445DD09-A8AD-4EEA-AF47-693318E0C745Q36003382-C9BB81AE-3BAE-43E0-8455-B802ACEB9139Q36247371-7738AC18-81C5-4DAE-8E5B-BF692A165EF1Q36431960-009A0566-C5BC-4919-94DC-90624082C2F6Q36449189-045AA02F-0241-4887-AE44-61AB5667BF70Q36511211-EA9EF8EF-F508-4911-A45D-C50F7C55B7B1Q36747054-D4589E45-015D-46A6-B81C-C04AD319EFC2Q37212465-D89B473E-434E-4FD0-9331-757E939517A3Q38363798-5CC5238D-4A18-4413-A6A3-C657D7622815Q40586505-B41411A8-8833-4173-A90C-E1B0D9636E08Q42372774-14B8D95E-7459-4CC9-859E-FB640C025418Q48124372-3EF93EAA-FCED-4C3B-B81E-3CFB6E1233A2Q49829375-835427EB-81D7-4CD5-87B3-1D33245BA648Q49973045-2A7C2368-F4EB-4AE2-8CF1-FDDB0BF3E812Q50072876-680054DB-BBD7-4202-AA93-F05D49BCC10BQ55431567-E6F69774-A845-45D1-9566-0853E8C13409
P2860
Relief from Zmp1-mediated arrest of phagosome maturation is associated with facilitated presentation and enhanced immunogenicity of mycobacterial antigens.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Relief from Zmp1-mediated arre ...... ity of mycobacterial antigens.
@ast
Relief from Zmp1-mediated arre ...... ity of mycobacterial antigens.
@en
type
label
Relief from Zmp1-mediated arre ...... ity of mycobacterial antigens.
@ast
Relief from Zmp1-mediated arre ...... ity of mycobacterial antigens.
@en
prefLabel
Relief from Zmp1-mediated arre ...... ity of mycobacterial antigens.
@ast
Relief from Zmp1-mediated arre ...... ity of mycobacterial antigens.
@en
P2093
P2860
P50
P356
P1476
Relief from Zmp1-mediated arre ...... city of mycobacterial antigens
@en
P2093
Antonia Fettelschoss
Beat Amstutz
Leonhard Held
Petra Selchow
Pål Johansen
Thomas M Kündig
Ying Waeckerle-Men
P2860
P304
P356
10.1128/CVI.00015-11
P577
2011-04-06T00:00:00Z